NCT03992131 2024-01-16A Study to Evaluate Rucaparib in Combination With Other Anticancer Agents in Participants With a Solid Tumor (SEASTAR)pharmaand GmbHPhase 1/2 Terminated25 enrolled 11 charts
NCT04042116 2022-12-20A Study to Evaluate Lucitanib in Combination With Nivolumab in Patients With a Solid TumorClovis Oncology, Inc.Phase 1/2 Suspended227 enrolled